| 0.2459 Data as of 1:44pm ET |  -0.0049 / -1.95%Today’s Change | 0.18 Today|||52-Week Range 1.10 | -1.95% Year-to-Date |
| Previous close | 0.25 |
| Today’s open | 0.25 |
| Day’s range | 0.24 - 0.25 |
| Volume | 182,699 |
| Average volume (3 months) | 784,246 |
| Market cap | $41.9M |
| Dividend yield | -- |
| Earnings growth (last year) | -71.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | +32.30% |
| P/E ratio | NM |
| Price/Sales | 166.04 |
| Price/Book | 0.93 |
| Today’s change | Today’s % change | |
|---|---|---|
| MSTXMast Therapeutics In... | +0.01 | +3.07% |
| VTUSVentrus Biosciences ... | +0.06 | +2.74% |
| CPRXCatalyst Pharmaceuti... | -0.04 | -4.52% |
| BGMDBG Medicine Inc | -0.03 | -2.41% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $213.0K |
| Annual profit (last year) | -$17.4M |
| Net profit margin | -8,147.42% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President, Chief Executive Officer & CSO William A. Carter, MD |
Senior Vice President- Operations Wayne S. Springate |
Corporate headquarters Philadelphia, Pennsylvania |
.
